347 related articles for article (PubMed ID: 25205593)
21. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.
Olsson A; Csajbok L; Ost M; Höglund K; Nylén K; Rosengren L; Nellgård B; Blennow K
J Neurol; 2004 Jul; 251(7):870-6. PubMed ID: 15258792
[TBL] [Abstract][Full Text] [Related]
22. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
Kuhnke D; Jedlitschky G; Grube M; Krohn M; Jucker M; Mosyagin I; Cascorbi I; Walker LC; Kroemer HK; Warzok RW; Vogelgesang S
Brain Pathol; 2007 Oct; 17(4):347-53. PubMed ID: 17610523
[TBL] [Abstract][Full Text] [Related]
23. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
[TBL] [Abstract][Full Text] [Related]
24. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-
Swaminathan SK; Zhou AL; Ahlschwede KM; Curran GL; Lowe VJ; Li L; Kandimalla KK
J Pharmacol Exp Ther; 2020 Nov; 375(2):308-316. PubMed ID: 32778535
[TBL] [Abstract][Full Text] [Related]
25. Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis.
Lai PH; Wang TH; Zhang NY; Wu KC; Yao CJ; Lin CJ
J Neuroinflammation; 2021 Jan; 18(1):35. PubMed ID: 33516259
[TBL] [Abstract][Full Text] [Related]
26. Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system.
Marques MA; Kulstad JJ; Savard CE; Green PS; Lee SP; Craft S; Watson GS; Cook DG
J Alzheimers Dis; 2009; 16(2):325-9. PubMed ID: 19221422
[TBL] [Abstract][Full Text] [Related]
27. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
Deane R; Bell RD; Sagare A; Zlokovic BV
CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C.
de Almeida SM; Ribeiro CE; Rotta I; Piovesan M; Tang B; Vaida F; Raboni SM; Letendre S; Potter M; Batistela Fernandes MS; Ellis RJ;
J Neurovirol; 2018 Feb; 24(1):28-40. PubMed ID: 29063514
[TBL] [Abstract][Full Text] [Related]
29. Age-dependent inverse correlations in CSF and plasma amyloid-β(1-42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice.
Cho SM; Lee S; Yang SH; Kim HY; Lee MJ; Kim HV; Kim J; Baek S; Yun J; Kim D; Kim YK; Cho Y; Woo J; Kim TS; Kim Y
Sci Rep; 2016 Feb; 6():20185. PubMed ID: 26830653
[TBL] [Abstract][Full Text] [Related]
30. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.
Jaeger LB; Dohgu S; Sultana R; Lynch JL; Owen JB; Erickson MA; Shah GN; Price TO; Fleegal-Demotta MA; Butterfield DA; Banks WA
Brain Behav Immun; 2009 May; 23(4):507-17. PubMed ID: 19486646
[TBL] [Abstract][Full Text] [Related]
31. Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model.
Vulin M; Zhong Y; Maloney BJ; Bauer B; Hartz AMS
Fluids Barriers CNS; 2023 Oct; 20(1):70. PubMed ID: 37803468
[TBL] [Abstract][Full Text] [Related]
32. Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.
Qosa H; LeVine H; Keller JN; Kaddoumi A
Biochim Biophys Acta; 2014 Sep; 1842(9):1806-15. PubMed ID: 24997450
[TBL] [Abstract][Full Text] [Related]
33. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
Dobrowolska JA; Kasten T; Huang Y; Benzinger TL; Sigurdson W; Ovod V; Morris JC; Bateman RJ
PLoS One; 2014; 9(3):e89998. PubMed ID: 24646516
[TBL] [Abstract][Full Text] [Related]
34. Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.
Lucey BP; Mawuenyega KG; Patterson BW; Elbert DL; Ovod V; Kasten T; Morris JC; Bateman RJ
JAMA Neurol; 2017 Feb; 74(2):207-215. PubMed ID: 27992627
[TBL] [Abstract][Full Text] [Related]
35. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
[TBL] [Abstract][Full Text] [Related]
36. Ketone Bodies Promote Amyloid-β
Versele R; Corsi M; Fuso A; Sevin E; Businaro R; Gosselet F; Fenart L; Candela P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023814
[TBL] [Abstract][Full Text] [Related]
37. Amyloid beta
Ochiai Y; Uchida Y; Tachikawa M; Couraud PO; Terasaki T
J Neurochem; 2019 Aug; 150(4):385-401. PubMed ID: 31091338
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies.
Elfakhri KH; Duong QV; Langley C; Depaula A; Mousa YM; Lebeouf T; Cain C; Kaddoumi A
Neuroscience; 2018 May; 379():269-280. PubMed ID: 29596966
[TBL] [Abstract][Full Text] [Related]
39. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
40. PPARγ agonists regulate bidirectional transport of amyloid-β across the blood-brain barrier and hippocampus plasticity in db/db mice.
Wang H; Chen F; Zhong KL; Tang SS; Hu M; Long Y; Miao MX; Liao JM; Sun HB; Hong H
Br J Pharmacol; 2016 Jan; 173(2):372-85. PubMed ID: 26507867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
